Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
--------------------------------------------------------------------
Source: The Jerusalem Post
Published: 2026-05-11 23:02 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Military & Defence, World News, Business & Economy, Technology
--------------------------------------------------------------------
Snippet:
Cellular Intelligence has acquired global rights to Novo Nordisk’s clinical‑stage cell therapy program for Parkinson’s disease, a fast-growing neurodegenerative disease that affects close to 12 million people worldwide, the company announced today.
--------------------------------------------------------------------